Low molecular weight heparin prophylaxis to prevent VTE events in hospitalized oncology patients.
Year: 2026
Type: article
Abstract: Low molecular weight heparin is a well-supported prophylactic option to effectively reduce the risk of VTE events in hospitalized oncology patients, with guidelines endorsing its use during hospital stays.
Author: Tripdatabase
Language: English
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7236337389
